IP Library Granted Patent US 10,517,529
Granted Patent B2
US 10,517,529 · App. 15/250,917 · Granted Dec 31, 2019

Functional assessment and treatment catheters and methods for their use in the lung

Inventors: Ajit Nair (Milpitas, CA); Son Gia (San Jose, CA); Roger Farhnoltz (Fremont, CA); Nikolai Aljuri (Hillsborough, CA)
Assignee: Pulmonx Corporation
A61B5/4836A61B5/08A61B5/085A61B5/097A61B5/6853A61B17/12104A61M16/04A61M16/0406A61M25/0075A61M25/0662A61F2002/043A61M2025/0004A61M2025/0681
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,517,529
App. No.
15/250,917
Granted
Dec 31, 2019
Kind
B2
Abstract

Lung conditions are diagnosed and optionally treated using a functional assessment catheter or a functional lung assessment and treatment catheter. A flow restrictive component is initially placed in a bronchus or lung passageway upstream from a diseased lung region. The isolated lung region is then functionally assessed through the catheter, while the flow restrictive component remains in place. If the patient is a good candidate for treatment by occlusive or restrictive treatment techniques, the flow resistive component may be left in place. If the patient is not suitable for such treatment, the flow resistive component may be removed.

Claims (16)

1. A functional assessment catheter for the lungs, said catheter comprising:

a catheter shaft having a distal and a proximal end, and a central passage there between;

a flow restrictive component disposed at the distal end of the catheter shaft, wherein the flow restrictive component has an expanded configuration and a contracted configuration;

an obturator disposed in the central passage and shiftable between a distally advanced position where it engages and elongates the flow restrictive component to cause the component to assume the contracted configuration, and a proximally retracted position where it allows the flow restrictive component to shorten and return to the expanded configuration; and

a release mechanism for selectively detaching the flow restrictive component from the catheter shaft; wherein the release mechanism comprises a sleeve attached at a proximal end of the flow restrictive component and an attachment ball projects from a proximal end of the sleeve.

2. A functional assessment catheter as in claim 1 , wherein the flow restrictive component comprises a resilient scaffold and an elastomeric covering.

3. A functional assessment catheter as in claim 1 , wherein the resilient scaffold comprises counter wound helical supports.

4. A functional assessment catheter as in claim 3 , comprising an opening in a distal side of the elastomeric covering of the flow restrictive component.

5. A functional assessment and treatment catheter for the lungs, said catheter comprising:

a catheter shaft having a distal end, a proximal end, and a central lumen therethrough;

a detachable flow restrictive component releasably secured to the distal end of the catheter shaft, said flow restrictive component having an expanded configuration for sealing to an inner wall of a lung passage and a contracted configuration to permit positioning within the lung passage;

a release mechanism for selectively detaching the flow restrictive component from the catheter shaft; wherein the release mechanism comprises a sleeve attached at a proximal end of the flow restrictive component and an attachment ball projects from a proximal end of the sleeve; and

an obturator disposed in the central lumen, and shiftable between a distally advanced position where it engages and elongates the flow restrictive component to cause the component to assume the contracted configuration, and a proximally retracted position where it allows the flow restrictive component to shorten and return to the expanded configuration;

wherein a flow path is formed through the flow restrictive component.

6. A functional assessment and treatment catheter as in claim 5 , wherein the flow restrictive component comprises a resilient scaffold and an elastomeric covering.

7. A functional assessment and treatment catheter as in claim 6 , wherein the resilient scaffold comprises counter wound helical supports.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
SECURITY INTEREST Recorded Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
SECURITY INTEREST Recorded Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2019
From: ALJURI, NIKOLAI
To: PULMONX
Reel/Frame 048643/0413 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2019
From: NAIR, AJIT; GIA, SON; FARHNOLTZ, ROGER
To: PULMONX
Reel/Frame 048643/0385 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
Continuity (5)
Continuation 13689344 · Nov 29, 2012
Division 11845296 · Aug 27, 2007
Provisional Application 60823734 · Aug 28, 2006
Provisional Application 60828496 · Oct 6, 2006
Related Publication 20170128004A1 · May 11, 2017